COVID-19: stewardship of diagnostic tests for bacterial co-infection

Affiliations

Comment

Tom G S Williams et al. Lancet Microbe. 2021 Nov.

. 2021 Nov;2(11):e570.

doi: 10.1016/S2666-5247(21)00238-X. Epub 2021 Aug 26.

¹ Department of Infection, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London, UK.

No abstract available

Comment on

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD, Fairfield CJ, Drake TM, Turtle L, Seaton RA, Wootton DG, Sigfrid L, Harrison EM, Docherty AB, de Silva TI, Egan C, Pius R, Hardwick HE, Merson L, Girvan M, Dunning J, Nguyen-Van-Tam JS, Openshaw PJM, Baillie JK, Semple MG, Ho A; ISARIC4C investigators. Russell CD, et al. Lancet Microbe. 2021 Aug;2(8):e354-e365. doi: 10.1016/S2666-5247(21)00090-2. Epub 2021 Jun 2. Lancet Microbe. 2021. PMID: 34100002 Free PMC article.

1. Russell CD, Fairfield CJ, Drake TM. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021;2:e354–e365. - PMC - PubMed
1. National Institute for Health and Care Excellence . National Institute for Health and Care Excellence; London: 2021. COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): evidence reviews 6 and 7: monitoring and referral. - PubMed